Yiqiong Ma

972 total citations
19 papers, 596 citations indexed

About

Yiqiong Ma is a scholar working on Molecular Biology, Nephrology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Yiqiong Ma has authored 19 papers receiving a total of 596 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 7 papers in Nephrology and 5 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Yiqiong Ma's work include Mitochondrial Function and Pathology (6 papers), Renal Diseases and Glomerulopathies (6 papers) and Birth, Development, and Health (5 papers). Yiqiong Ma is often cited by papers focused on Mitochondrial Function and Pathology (6 papers), Renal Diseases and Glomerulopathies (6 papers) and Birth, Development, and Health (5 papers). Yiqiong Ma collaborates with scholars based in China, Switzerland and United States. Yiqiong Ma's co-authors include Guohua Ding, Qian Yang, Yingjie Yang, Wei Liang, Jijia Hu, Wei Liang, Jun Feng, Yanqin Fan, Zhaowei Chen and Zhao Gao and has published in prestigious journals such as Scientific Reports, International Journal of Molecular Sciences and Molecular Biology of the Cell.

In The Last Decade

Yiqiong Ma

19 papers receiving 592 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yiqiong Ma China	14	276	199	79	69	66	19	596
Jijia Hu China	18	397 1.4×	294 1.5×	123 1.6×	83 1.2×	98 1.5×	35	808
Jun Feng China	18	363 1.3×	243 1.2×	108 1.4×	80 1.2×	74 1.1×	24	716
Fengjuan Huang China	15	369 1.3×	150 0.8×	98 1.2×	64 0.9×	45 0.7×	46	739
Vanessa Marchant Spain	12	244 0.9×	176 0.9×	72 0.9×	38 0.6×	97 1.5×	25	658
Mark A. Bryniarski United States	10	188 0.7×	76 0.4×	50 0.6×	66 1.0×	33 0.5×	14	411
Maria Mavilio Italy	17	331 1.2×	48 0.2×	123 1.6×	34 0.5×	83 1.3×	24	732
L. Jay Stallons United States	11	304 1.1×	263 1.3×	82 1.0×	88 1.3×	75 1.1×	12	656
Sayaka Arakawa Japan	11	183 0.7×	148 0.7×	59 0.7×	97 1.4×	70 1.1×	36	731
Fengxin Zhu China	16	383 1.4×	166 0.8×	46 0.6×	28 0.4×	58 0.9×	27	693
Jun Honjo Japan	12	240 0.9×	115 0.6×	61 0.8×	41 0.6×	202 3.1×	19	634

Countries citing papers authored by Yiqiong Ma

Since Specialization

Citations

This map shows the geographic impact of Yiqiong Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yiqiong Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yiqiong Ma more than expected).

Fields of papers citing papers by Yiqiong Ma

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yiqiong Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yiqiong Ma. The network helps show where Yiqiong Ma may publish in the future.

Co-authorship network of co-authors of Yiqiong Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Yiqiong Ma. A scholar is included among the top collaborators of Yiqiong Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yiqiong Ma. Yiqiong Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Feng, Jun, Feng Ling, Yushan Yan, et al.. (2025). SIRT3 deficiency aggravates mitochondrial metabolic disorder and podocyte injury in DKD via MPC2 acetylation. Cellular Signalling. 135. 112029–112029. 1 indexed citations

Wu, Yingchao, Yun Cao, Ling Feng, et al.. (2025). The natural compound stachyose targets SGLT2-mediated metabolic reprogramming to ameliorate diabetic kidney disease. Phytomedicine. 147. 157182–157182. 1 indexed citations

Ma, Yiqiong, et al.. (2023). Paracrine Effects of Renal Proximal Tubular Epithelial Cells on Podocyte Injury under Hypoxic Conditions Are Mediated by Arginase-II and TGF-β1. International Journal of Molecular Sciences. 24(4). 3587–3587. 3 indexed citations

Chen, Zhaowei, Wei Liang, Jijia Hu, et al.. (2022). Sirt6 deficiency contributes to mitochondrial fission and oxidative damage in podocytes via ROCK1‐Drp1 signalling pathway. Cell Proliferation. 55(10). e13296–e13296. 21 indexed citations

Feng, Jun, Zhaowei Chen, Yiqiong Ma, et al.. (2022). AKAP1 contributes to impaired mtDNA replication and mitochondrial dysfunction in podocytes of diabetic kidney disease. International Journal of Biological Sciences. 18(10). 4026–4042. 36 indexed citations

Ma, Yiqiong, et al.. (2022). Role of Arginase-II in Podocyte Injury under Hypoxic Conditions. Biomolecules. 12(9). 1213–1213. 6 indexed citations

Liang, Xiujie, Andrea Brenna, Yiqiong Ma, et al.. (2021). Hypoxia Induces Renal Epithelial Injury and Activates Fibrotic Signaling Through Up-Regulation of Arginase-II. Frontiers in Physiology. 12. 773719–773719. 15 indexed citations

Zhu, Zijing, Wei Liang, Zhaowei Chen, et al.. (2021). Mitoquinone Protects Podocytes from Angiotensin II‐Induced Mitochondrial Dysfunction and Injury via the Keap1‐Nrf2 Signaling Pathway. Oxidative Medicine and Cellular Longevity. 2021(1). 44 indexed citations

Ma, Yiqiong, Qian Yang, Jijia Hu, et al.. (2020). AKAP1 mediates high glucose‐induced mitochondrial fission through the phosphorylation of Drp1 in podocytes. Journal of Cellular Physiology. 235(10). 7433–7448. 53 indexed citations

10.

Ma, Yiqiong, Bo Diao, Cheng Chen, et al.. (2020). Epidemiological, Clinical, and Immunological Features of a Cluster of COVID-19–Contracted Hemodialysis Patients. Kidney International Reports. 5(8). 1333–1341. 37 indexed citations

11.

Su, Ke, Yiqiong Ma, Yujuan Wang, et al.. (2020). How we mitigated and contained the COVID-19 outbreak in a hemodialysis center: Lessons and experience. Infection Control and Hospital Epidemiology. 41(10). 1240–1242. 17 indexed citations

12.

Ma, Yiqiong, Zhaowei Chen, Jijia Hu, et al.. (2020). Sestrin‑2 regulates podocyte mitochondrial dysfunction�and apoptosis under high‑glucose conditions via AMPK. International Journal of Molecular Medicine. 45(5). 1361–1372. 37 indexed citations

13.

Feng, Jun, Yiqiong Ma, Zhaowei Chen, et al.. (2019). Mitochondrial pyruvate carrier 2 mediates mitochondrial dysfunction and apoptosis in high glucose-treated podocytes. Life Sciences. 237. 116941–116941. 30 indexed citations

14.

Fan, Yanqin, Qian Yang, Yingjie Yang, et al.. (2019). Sirt6 Suppresses High Glucose-Induced Mitochondrial Dysfunction and Apoptosis in Podocytes through AMPK Activation. International Journal of Biological Sciences. 15(3). 701–713. 141 indexed citations

15.

Ma, Yiqiong, et al.. (2019). Increased mitochondrial fission of glomerular podocytes in diabetic nephropathy. Endocrine Connections. 8(8). 1206–1212. 44 indexed citations

16.

Ma, Yiqiong, Qian Yang, Wei Liang, et al.. (2018). Role of c-Abl and nephrin in podocyte cytoskeletal remodeling induced by angiotensin II. Cell Death and Disease. 9(2). 185–185. 24 indexed citations

17.

Yang, Yingjie, Qian Yang, Jian Yang, Yiqiong Ma, & Guohua Ding. (2017). Angiotensin II induces cholesterol accumulation and injury in podocytes. Scientific Reports. 7(1). 10672–10672. 48 indexed citations

18.

Ma, Yiqiong, et al.. (2016). c-Abl contributes to glucose-promoted apoptosis via p53 signaling pathway in podocytes. Diabetes Research and Clinical Practice. 113. 171–178. 9 indexed citations

19.

Yang, Qian, Yiqiong Ma, Yipeng Liu, et al.. (2015). Angiotensin II down-regulates nephrin–Akt signaling and induces podocyte injury: role of c-Abl. Molecular Biology of the Cell. 27(1). 197–208. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact